FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2742425991> ?p ?o ?g. }

• W2742425991 abstract "ABSTRACT Introduction – Aim. Cervical cancer, although largely preventable, remains the most common cause of cancer mortality amongst women in low-resource countries. Epidemiological and clinical studies have clearly established human papillomavirus (HPV) types 16 and 18 as the main cause of invasive cervical cancer (ICC). Despite the high burden of HPV (39.0%), high mortality due to cervical cancer in Cameroon, and availability of vaccines, quality reviews on HPV to inform effective public health control strategies are lacking. Methods. We carried out systematically search of 12 major electronic databases for published articles and grey literature up to May 2016 as per PRISMA guidelines. We included studies without language restriction that reported the prevalence of HPV genotypes 16 and 18 among Cameroonian women. Data was extracted and study quality appraised from 5 articles. Results. Our search strategy resulted in five eligible articles, including a total of 1856 women, age ≥18 years tested for HPV. The overall HPV prevalence in Cameroon observed in our systematic review was 36.3% (673/1856). The prevalence of HPV 16 and 18 were 13.0% and 6.5% in women with normal cytology, 18.2% and 4.6% in ASCUS, 29.7% and 27.0% in HSIL, 22.2% and 5.3% in women with ICC respectively. Conclusion. Our study shows that HPV16 and 18 account for 27.5% of ICC cases among Cameroonian women with a high HPV prevalence in women > 25 years of age. These findings greatly support increased efforts in screening for high risk HPV genotypes and the introduction and roll out of HPV prophylactic vaccines in Cameroon. RESUME Objectifs. Malgre le fardeau eleve du virus du papillomavirus humain (VPH) (39,0%), la mortalite elevee due au cancer du col de l'uterus au Cameroun et la disponibilite des vaccins, les revues de qualite sur le VPH pour renforcer l'efficacite des strategies de controle en sante publique font defaut. Methodes. Nous avons fait une revue systematique a la recherche de 12 bases de donnees electroniques majeures pour les articles publies et la litterature grise jusqu'en mai 2016, conformement aux lignes directrices de PRISMA. Notre critere d’inclusion etait les etudes sans restriction de langue qui ont signale la prevalence des genotypes du VPH 16 et 18 parmi les femmes camerounaises. Resultats. Notre strategie de recherche a abouti a cinq articles eligibles, donnant 1856 femmes, âgees de 18 ans testees pour le VPH. La prevalence globale du VPH au Cameroun observee dans notre etude etait de 36,3% (673/1856). VPH 16 et 18 representaient 6,25% et 3,28% respectivement. La prevalence du VPH 16 et 18 etait de 13,0% et 6,5% chez les femmes ayant une cytologie normale et 5,3% chez les femmes avec cancer invasif du col (CIC). Conclusion. Notre etude montre que HPV 16 et 18 representent 27,5% des cas de CIC chez les femmes camerounaises avec une forte prevalence du VPH chez les femmes > 25 ans. Ces resultats appuient grandement les efforts accrus dans le depistage des genotypes de HPV a haut risque et l'introduction et le deploiement des vaccins prophylactiques contre le VPH au Cameroun." @default.
• W2742425991 created "2017-08-17" @default.
• W2742425991 creator A5003987049 @default.
• W2742425991 creator A5012518982 @default.
• W2742425991 creator A5020585419 @default.
• W2742425991 creator A5043206813 @default.
• W2742425991 creator A5045663076 @default.
• W2742425991 creator A5062977354 @default.
• W2742425991 creator A5069340320 @default.
• W2742425991 creator A5070565819 @default.
• W2742425991 creator A5071286043 @default.
• W2742425991 creator A5073155285 @default.
• W2742425991 creator A5074082091 @default.
• W2742425991 creator A5077155502 @default.
• W2742425991 creator A5084274561 @default.
• W2742425991 date "2017-07-26" @default.
• W2742425991 modified "2023-09-25" @default.
• W2742425991 title "Oncogenic Human Papillomavirus Genotypes 16 and 18 Prevalence Among Women with Normal Cervical Cytology and Neoplasia in Cameroon: A Systematic Review" @default.
• W2742425991 cites W1964927845 @default.
• W2742425991 cites W1969635101 @default.
• W2742425991 cites W1970197840 @default.
• W2742425991 cites W1971139416 @default.
• W2742425991 cites W1975656660 @default.
• W2742425991 cites W1998280193 @default.
• W2742425991 cites W2003194103 @default.
• W2742425991 cites W2008465789 @default.
• W2742425991 cites W2012868689 @default.
• W2742425991 cites W2015121818 @default.
• W2742425991 cites W2020386919 @default.
• W2742425991 cites W2039728969 @default.
• W2742425991 cites W2045116756 @default.
• W2742425991 cites W2045525748 @default.
• W2742425991 cites W2047580791 @default.
• W2742425991 cites W2066860562 @default.
• W2742425991 cites W2083182154 @default.
• W2742425991 cites W2086679030 @default.
• W2742425991 cites W2100367404 @default.
• W2742425991 cites W2101196984 @default.
• W2742425991 cites W2106787323 @default.
• W2742425991 cites W2107328434 @default.
• W2742425991 cites W2139631507 @default.
• W2742425991 cites W2139738127 @default.
• W2742425991 cites W2140481064 @default.
• W2742425991 cites W2144203012 @default.
• W2742425991 cites W2145328132 @default.
• W2742425991 cites W2160209388 @default.
• W2742425991 cites W2160407895 @default.
• W2742425991 cites W2172635076 @default.
• W2742425991 cites W2314811924 @default.
• W2742425991 cites W600225349 @default.
• W2742425991 cites W79882934 @default.
• W2742425991 hasPublicationYear "2017" @default.
• W2742425991 type Work @default.
• W2742425991 sameAs 2742425991 @default.
• W2742425991 citedByCount "0" @default.
• W2742425991 crossrefType "journal-article" @default.
• W2742425991 hasAuthorship W2742425991A5003987049 @default.
• W2742425991 hasAuthorship W2742425991A5012518982 @default.
• W2742425991 hasAuthorship W2742425991A5020585419 @default.
• W2742425991 hasAuthorship W2742425991A5043206813 @default.
• W2742425991 hasAuthorship W2742425991A5045663076 @default.
• W2742425991 hasAuthorship W2742425991A5062977354 @default.
• W2742425991 hasAuthorship W2742425991A5069340320 @default.
• W2742425991 hasAuthorship W2742425991A5070565819 @default.
• W2742425991 hasAuthorship W2742425991A5071286043 @default.
• W2742425991 hasAuthorship W2742425991A5073155285 @default.
• W2742425991 hasAuthorship W2742425991A5074082091 @default.
• W2742425991 hasAuthorship W2742425991A5077155502 @default.
• W2742425991 hasAuthorship W2742425991A5084274561 @default.
• W2742425991 hasConcept C104317684 @default.
• W2742425991 hasConcept C107130276 @default.
• W2742425991 hasConcept C121608353 @default.
• W2742425991 hasConcept C126322002 @default.
• W2742425991 hasConcept C131872663 @default.
• W2742425991 hasConcept C135763542 @default.
• W2742425991 hasConcept C142724271 @default.
• W2742425991 hasConcept C174618031 @default.
• W2742425991 hasConcept C185592680 @default.
• W2742425991 hasConcept C18823058 @default.
• W2742425991 hasConcept C2776511402 @default.
• W2742425991 hasConcept C2777083264 @default.
• W2742425991 hasConcept C2778220009 @default.
• W2742425991 hasConcept C2778580637 @default.
• W2742425991 hasConcept C29456083 @default.
• W2742425991 hasConcept C2994532551 @default.
• W2742425991 hasConcept C55493867 @default.
• W2742425991 hasConcept C59822182 @default.
• W2742425991 hasConcept C71924100 @default.
• W2742425991 hasConcept C86803240 @default.
• W2742425991 hasConceptScore W2742425991C104317684 @default.
• W2742425991 hasConceptScore W2742425991C107130276 @default.
• W2742425991 hasConceptScore W2742425991C121608353 @default.
• W2742425991 hasConceptScore W2742425991C126322002 @default.
• W2742425991 hasConceptScore W2742425991C131872663 @default.
• W2742425991 hasConceptScore W2742425991C135763542 @default.
• W2742425991 hasConceptScore W2742425991C142724271 @default.
• W2742425991 hasConceptScore W2742425991C174618031 @default.
• W2742425991 hasConceptScore W2742425991C185592680 @default.
• W2742425991 hasConceptScore W2742425991C18823058 @default.
• W2742425991 hasConceptScore W2742425991C2776511402 @default.

• next